Phibro Animal Health (NASDAQ:PAHC) Announces Earnings Results

Phibro Animal Health (NASDAQ:PAHC) issued its earnings results on Wednesday. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.14, Zacks reports. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. Phibro Animal Health updated its FY 2025 guidance to 1.870-2.010 EPS.

Phibro Animal Health Price Performance

PAHC stock opened at $24.58 on Friday. The firm has a 50 day moving average of $21.87 and a 200-day moving average of $21.60. The firm has a market capitalization of $995.49 million, a P/E ratio of 57.16, a price-to-earnings-growth ratio of 0.56 and a beta of 0.52. Phibro Animal Health has a 12 month low of $10.03 and a 12 month high of $25.98. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.95%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is presently 111.63%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on PAHC. Barclays boosted their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. Morgan Stanley boosted their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Finally, StockNews.com cut shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $20.50.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.